We are thrilled to announce that FlexifyMe, a deep-tech-based health-tech platform focused on chronic pain management, has successfully closed its seed funding round, led by Flipkart Ventures. The round also saw participation from Key Venture’s Investor Forum.
Key Venture’s Investment Banking vertical advised FlexifyMe on this transaction. After establishing a successful investment banking practice for early and growth-stage startups, Key Venture has launched an invite-only Investor Forum (KVIF) to increase awareness about startups as a value-generative asset class, provide networking opportunities for earnest investors and ecosystem players and support entrepreneurs with funding and industry connects. KVIF strives to bring opportunities such as FlexiFyMe to HNIs where institutional investors are leading the round and providing the startups the required mentoring and support.
About FlexifyMe
Founded in 2021 by serial entrepreneurs Manjeet Singh and Amit Bhayani, FlexifyMe is on a mission to revolutionize traditional physiotherapy visits through its innovative health-tech platform powered by AI motion tracking technology. The platform targets the growing population of over 1.7 billion people worldwide who suffer from musculoskeletal disorders, including chronic conditions like back pain, spondylitis, scoliosis, and arthritis. Conventional solutions, such as medications and medical procedures, have proven to be short-term with high rates of problem recurrence and associated high costs, causing delays in treatment.
Business Model
FlexifyMe introduces a unique combination of human expertise (online physiotherapists, orthopaedics) and machine intelligence (AI motion coach) to enable individuals to treat chronic pain from the comfort of their homes. The team has honed the motion coach using advanced vision AI technology, allowing it to identify body imbalances, postural issues, and alignment problems. Certified physiotherapists, yoga therapists, and orthopaedic surgeons are also part of the platform, ensuring a consistent and result-oriented approach to treatment.
Key Achievements
Their innovative approach has achieved an impressive 100% success rate in treatment, reducing physiotherapy costs by up to 80%. As a result, FlexifyMe has reached significant milestones, generating $500,000 in Annual Recurring Revenue (ARR), and establishing a presence in over 20 countries within just 18 months since its inception, all with less than $300,000 in funding.
About The Funding Round
In its recent Seed Funding Round, FlexifyMe successfully raised $1Mn, with Flipkart Ventures leading the investment. The round also witnessed the participation of other notable investors, including IvyCap Ventures, Emcure Family Office, Venture Catalysts, Point One Capital, GSF Accelerator and iHub Anubhuti (the incubation centre of IIIT Delhi).
Among the existing investors supporting FlexifyMe are Ravi Bhushan (Founder, BrightChamps), Amit Ratanpal (Founder, BlincInvest), and Sachin Anand (Sales Head APAC, Intel Corporation), among others.
Vision for the Future
The funds raised in this round will be allocated to further enhance the AI motion coach, making it available in local languages, and expanding the platform’s presence in the MENA and North American regions.
Key Venture Investment Banking played a significant role as the financial advisor to FlexifyMe during this successful transaction.
The Founders’ Thoughts On Working With Key Venture
Manjeet Singh, Co-Founder of FlexifyMe, expressed his gratitude, saying, “Key Venture understood the need for our solution and navigated us through the entire fundraising process. This investment offers immense opportunity and propels us closer to our vision of solving chronic pain naturally on a global scale. Our growth journey involves an easily accessible full-stack platform solving for all hormonal ailments.”
Amit Bhayani, Co-Founder of FlexifyMe, shared his insights, “Over time, the medical field has witnessed valuable innovation and evolution enabling people to live healthier and safer lives. Digital therapeutics is a significant chapter in the advancement of the medical field. Key Venture’s experience and expertise in the healthcare ecosystem were instrumental in building partnerships with the right stakeholders.”
Nidhi Saraf, CEO & Founder of Key Venture, “FlexifyMe plays a pivotal role in transforming chronic care for musculoskeletal disorders through its deep-tech product. The FlexifyMe platform helps make physiotherapy affordable and accessible for all. Given the sedentary lifestyle of our working population, this is a need of the hour. Through a differentiated and result-oriented approach, FlexifyMe is poised to be the go-to treatment option for musculoskeletal disorders”.
About Key Venture
Key Venture is an Investment Bank specialising in assisting early and growth-stage companies with mergers and acquisitions and raising capital from institutions, including VCs, PEs, corporates, family offices, and HNIs.
Founded by Nidhi Saraf (CEO) and Hars Saraf (COO), Key Venture plays a crucial role in supporting promising startups and companies in achieving their growth and funding objectives within the healthcare and technology sectors.
About Key Venture Investor Forum (KVIF)
Key Venture Investor Forum (KVIF) is an invite-only community tailored for UHNIs, VCs, and corporates globally. The platform offers a curated gateway to investment prospects and a vibrant ecosystem that fosters diverse portfolios, collaborations, and unparalleled networking opportunities, uniting innovative startups with seasoned investors.
For Inquiries, Please Contact:
Nidhi Saraf, Founder & CEO – [email protected]
Hars Saraf, Co-Founder & COO – [email protected]